Rapid Diagnostic Test
/
Abbott RDT Infectious Diseases

ID NOW™ COVID-19 2.0

Key Features

Molecular. In minutes.™

 

Empowering clinicians to make faster decisions with diagnostic results in real time

 

The clia-waived id nowtm covid-19 2.0 assay delivers reliable molecular results in just minutes, giving you real-time access to the information you need to make actionable decisions right at the point of care.

BENEFITS

RAPID RESULTS
Positive results as early as 6 minutes, negative results in 12 minutes
UNCOMPROMISED PERFORMANCE
Nucleic Acid Amplification Technology (NAAT), providing molecular results in a fraction of the time it takes traditional lab tests
SIMPLE, SMART TECHNOLOGY
CLIA-waived; requires minimum training with easy on-screen steps to guide users
POWERFUL FLEXIBILITY
You can decide which tests to run based on patient presentation, circulating prevalence and seasonality of infectious diseases

Product Information

Item
Description
Time to results
5 minutes
Swab Type
Uses direct nasal or nasopharyngeal swabs
ID NOW instrument dimensions
8.2” W x 5.7” H x 7.6” D (207 mm W x 145 mm H x 194 mm D
Shelf-life
The ID NOW Platform features bidirectional connectivity to support easy data integration from multiple instruments to hospital/lab information system.